Home / Products / Musculoskeletal System / Human Femoral Osteoblasts

Human Femoral Osteoblasts

Cat. No. ARP0155
Product Type:

Primary Cells

Species:

Homo sapiens (Human)

Tissue Source:

Bone (femur)

In stock
$1,800.00 / Vial
Ask a Question

Short Description

Research on the Human Femoral Osteoblasts is essential to the study of osteoporosis, osteogenesis imperfecta, Paget's disease of bone, bone metastasis (e.g., breast/prostate cancer), and medication-related osteonecrosis of the jaw (MRONJ). The femur, also known as the thigh bone, is the longest tubular bone in the human body. Its upper end, the head of the femur, articulates with the acetabulum to form the hip joint, while its lower end connects with the patella and the upper tibia to form the knee joint. The Human Femoral Osteoblasts are to be used with Human Femoral Osteoblast Medium (Cat. No. ACM0155). This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Species:
Homo sapiens (Human)
Cell Type:
Osteoblasts
Tissue Source:
Bone (femur)

Cell Engineering Information

Immortalization Information

Culture Conditions

Growth medium:
Human Femoral Osteoblast Medium (ARM0155)
Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".